(Q40527785)

English

Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine

scientific article published on September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

0 references

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christine Luxemburger

8

object named as

Christine Luxemburger

0 references

author name string

Bruno Guy

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pornthep Chanthavanich

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sophie Gimenez

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Chukiat Sirivichayakul

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Arunee Sabchareon

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sarah Begue

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sutee Yoksan

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Christine Luxemburger

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jean Lang

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

27-28

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3563-3574

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

describes a project that uses

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Antibody-enhanced dengue virus infection in primate leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Immunological enhancement and the pathogenesis of dengue haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Immunopathogenesis of Dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Live attenuated tetravalent dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Human skin Langerhans cells are targets of dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.042

7 January 2021

Identifiers

10.1016/J.VACCINE.2004.03.042

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40527785&oldid=1900001563"